Literature DB >> 16054753

Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.

Jian-Tao Bian1, Jun-Wu Zhang, Zhen-Xin Zhang, Hua-Lu Zhao.   

Abstract

A functional polymorphism in the coding region of brain-derived neurotrophic factor (BDNF) gene (196 A/G, Met66Val) has recently been reported to be associated with Alzheimer's disease (AD) and with an overrepresentation of G allele in AD patients, but different results have also been presented. We conducted a case-control study to analyze the association between the BDNF A/G polymorphism and sporadic AD in a sample composed of 203 AD patients and 239 controls from Mainland Chinese Han population. No association between the polymorphism and AD, no association between the polymorphism and age at onset in AD, and no significant interaction between BDNF and apolipoprotein E (APOE) genotype were detected in either the total or the male samples. However, a significantly high frequency of the GG genotype in the female controls compared with the female patients was detected. A postponed age at onset in the female patients with the GG genotype was also observed. These results suggest that the GG genotype has a protection effect from AD development in females. A significant low frequency of AD patients with the BDNF GG genotype in the AD APOEepsilon4 carriers compared with the frequency of the controls with the BDNF GG genotype in the control APOEepsilon4 carriers was also detected in the female individuals, suggesting that the BDNF GG genotype may reduce the effect of APOEepsilon4 on AD risk in females. Additionally, low frequencies of BDNF G allele and GG genotype were revealed in Chinese when compared with that in the other race populations so far reported.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054753     DOI: 10.1016/j.neulet.2005.07.009

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  A transdisciplinary model integrating genetic, physiological, and psychological correlates of voluntary exercise.

Authors:  Angela Bryan; Kent E Hutchison; Douglas R Seals; David L Allen
Journal:  Health Psychol       Date:  2007-01       Impact factor: 4.267

2.  Association of OGG1 and DLST promoter methylation with Alzheimer's disease in Xinjiang population.

Authors:  Wei Chen; Xiaohui Zhou; Yali Duan; Ting Zou; Guili Liu; Xiuru Ying; Qinwen Wang; Shiwei Duan
Journal:  Exp Ther Med       Date:  2018-07-26       Impact factor: 2.447

Review 3.  Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy.

Authors:  Subrata Pramanik; Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2016-11-05       Impact factor: 5.590

4.  Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory.

Authors:  Ana Kim; Anne M Fagan; Alison M Goate; Tammie L S Benzinger; John C Morris; Denise Head
Journal:  Cogn Affect Behav Neurosci       Date:  2015-09       Impact factor: 3.282

Review 5.  Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Front Neuroendocrinol       Date:  2006-10-20       Impact factor: 8.606

6.  Association of BDNF and BCHE with Alzheimer's disease: Meta-analysis based on 56 genetic case-control studies of 12,563 cases and 12,622 controls.

Authors:  Huihui Ji; Dongjun Dai; Yunliang Wang; Danjie Jiang; Xingyu Zhou; Peipei Lin; Xiaosui Ji; Jinfeng Li; Yuzheng Zhang; Honglei Yin; Rongrong Chen; Lina Zhang; Mingqing Xu; Shiwei Duan; Qinwen Wang
Journal:  Exp Ther Med       Date:  2015-03-03       Impact factor: 2.447

Review 7.  BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases.

Authors:  Bai Lu; Guhan Nagappan; Xiaoming Guan; Pradeep J Nathan; Paul Wren
Journal:  Nat Rev Neurosci       Date:  2013-05-15       Impact factor: 34.870

8.  BDNF variants, premorbid educational attainment, and disease characteristics in Alzheimer's disease: an exploratory study.

Authors:  Kristina F Zdanys; Timothy G Kleiman; Huiping Zhang; Fatih Ozbay; Martha G MacAvoy; Joel Gelernter; Christopher H van Dyck
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 9.  Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development.

Authors:  Dagmar E Ehrnhoefer; Bibiana K Y Wong; Michael R Hayden
Journal:  Nat Rev Drug Discov       Date:  2011-10-21       Impact factor: 84.694

10.  BDNF polymorphism predicts the rate of decline in skilled task performance and hippocampal volume in healthy individuals.

Authors:  M Millan Sanchez; D Das; J L Taylor; A Noda; J A Yesavage; A Salehi
Journal:  Transl Psychiatry       Date:  2011-10-25       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.